Nevro (NVRO)
(Delayed Data from NYSE)
$5.10 USD
+0.39 (8.28%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $5.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Nevro Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -92.21 | 3.00 | -131.36 | -83.07 | -103.69 |
Depreciation/Amortization & Depletion | 8.81 | 11.95 | 23.45 | 8.51 | 5.76 |
Net Change from Assets/Liabilities | -39.66 | -48.89 | 15.85 | 10.79 | -2.89 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 64.24 | 58.62 | 50.18 | 64.96 | 50.59 |
Net Cash From Operating Activities | -58.83 | 24.68 | -41.88 | 1.19 | -50.23 |
Property & Equipment | -8.59 | -7.54 | -12.34 | -6.03 | -3.47 |
Acquisition/ Disposition of Subsidiaries | -38.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 39.41 | 71.83 | 214.06 | -363.84 | 35.80 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -7.20 | 64.29 | 201.72 | -369.87 | 32.33 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.54 | 6.39 | 11.18 | 189.28 | 35.15 |
Issuance (Repayment) of Debt | 53.60 | 0.00 | -172.50 | 137.36 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -10.60 | -8.85 | -8.06 | 20.26 | -3.06 |
Net Cash from Financing Activities | 49.53 | -2.46 | -169.38 | 346.91 | 32.09 |
Effect of Exchange Rate Changes | 0.34 | -0.85 | -0.34 | 0.65 | 0.26 |
Net Change In Cash & Equivalents | -16.16 | 85.66 | -9.89 | -21.13 | 14.46 |
Cash at Beginning of Period | 120.98 | 35.32 | 45.20 | 66.33 | 51.87 |
Cash at End of Period | 104.82 | 120.98 | 35.32 | 45.20 | 66.33 |
Diluted Net EPS | -2.56 | 0.08 | -3.77 | -2.47 | -3.37 |
Fiscal Year End for Nevro Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -44.98 | -25.41 | -92.21 | -83.23 | -59.75 |
Depreciation/Amortization & Depletion | 7.18 | 3.72 | 8.81 | 6.43 | 4.26 |
Net Change from Assets/Liabilities | -17.89 | -16.93 | -39.66 | -19.23 | -21.39 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 14.93 | 5.96 | 64.24 | 46.12 | 33.07 |
Net Cash From Operating Activities | -40.77 | -32.66 | -58.83 | -49.91 | -43.82 |
Property & Equipment | -5.22 | -2.79 | -8.59 | -6.73 | -4.80 |
Acquisition/ Disposition of Subsidiaries | -0.05 | 0.16 | -38.02 | 0.00 | 0.00 |
Investments | 21.06 | 27.96 | 39.41 | 0.64 | -8.58 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 15.79 | 25.32 | -7.20 | -6.09 | -13.37 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.72 | 0.00 | 6.54 | 5.20 | 5.20 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 53.60 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -7.21 | -6.48 | -10.60 | -4.37 | -3.35 |
Net Cash from Financing Activities | -4.48 | -6.48 | 49.53 | 0.84 | 1.85 |
Effect of Exchange Rate Changes | -0.06 | -0.10 | 0.34 | -0.06 | 0.15 |
Net Change In Cash & Equivalents | -29.52 | -13.91 | -16.16 | -55.22 | -55.19 |
Cash at Beginning of Period | 104.82 | 104.82 | 120.98 | 120.98 | 120.98 |
Cash at End of Period | 75.31 | 90.91 | 104.82 | 65.76 | 65.79 |
Diluted Net EPS | -0.53 | -0.70 | -0.24 | -0.65 | -0.69 |